Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

NCT03362814 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

425

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV

Interventions

DRUG: Ravidasvir
DRUG: Danoprevir
DRUG: Ritonavir
DRUG: Ribavirin 100 MG
DRUG: Ravidasvir Placebo
DRUG: Danoprevir Placebo
DRUG: Ritonavir Placebo
DRUG: Ribavirin Placebo

Sponsor

Ascletis Pharmaceuticals Co., Ltd.